Bourque Industries Inc (BORK)

[gotmilk]

01/07/16 "Nice to see you positive (#msg-119678970) Doug, and here's hoping you're onto something."

Mike,

"Not so much." I now think.

I just made a very short telephone call to Chief Security Officer Juan Mendoza in reference towards items in the very recent financial.

To Cut To The Chase: The next communication from Bourque Industries to us Hurting in the Dark Shareholders will be from the next published financials.

Publish Date: Jan 18, 2016 + 3 months = April 2016 (hopefully not on All Fools' Day)
Report Title: Quarterly Report - OTC Disclosure
Period End Date: Nov 30, 2015 + 3 months = Feb 29, 2016 (3 more weeks)

Its very understood by all that have contacted Juan, since John Bourque's return in 2015, that Juan is under strict constraints in what details he is allowed to disclose.

To put it simply, Juan has not disclosed anything that can be used to extrapolated further from the published financials and the Jun 15, 2015 OTC Disclosure & News Service report.

I suggested that it would be very helpful for the Hurting in the Dark Shareholders to receive, using the OTC Disclosure & News Service, an explanation of which was included in the recent financial (specifics elaborated below) for a focus on the following text.

- requirements are in process of being met
- nullifying the June 12, 2014 agreement

It needs to be explained to the Hurting in the Dark Shareholders how the "nullifying" event changes the relationship John Bourque has with Bourque Industries in regards to Kryron and associated patents held by Bourque Industries and those only by John Bourque. Additionally it is unclear to me what status these 395,000,000 shares of Common Stock now possess, for can they be used by Bourque Industries for other transactions?

Publish Date: Jan 18, 2016
Report Title: Quarterly Report - OTC Disclosure
Period End Date: Nov 30, 2015
http://www.otcmarkets.com/financialReportViewer?symbol=BORK&id=149721

Security Information (as of: 09/30/2015)
The Company entered into an agreement with John Bourque on June 12, 2014 that called for the issuance of 395,000,000 shares of Common Stock to Mr. Bourque when he meets certain requirements for transferring intellectual property to the Company. These Board requirements are in process of being met and the shares were returned to the Transfer Agent to be re-deposited in the stock treasury nullifying the June 12, 2014 agreement.

Bourque Transactions:

On June 12, 2014, the Company issued 395,000,000 shares of common stock at the price of $.003 per share to John Bourque for the invention of currently produced and future patents. Under the agreement, Mr. Bourque is required to assign all future patents to the Company. The 395,000,000 shares were issued in Mr. Bourque's name; however, the certificate for such shares has not been delivered, and will not be delivered unless and until certain requirements are met, including the formal transfers to the Company of all patent rights. Mr. Bourque is in the process of meeting the Board requirements and the stock was returned to the Transfer Agent to re-deposit to the Treasury on October 12, 2015.

Patents

In the fiscal year ended May 31, 2012 the Company acquired intangible assets which it valued at $4,115,000. Of that amount, $3,695,000 was assigned to patents Mr. Bourque is to transfer to the Company. February 19, 2013, Mr. Bourque added an additional patent to the Bourque Industries patent portfolio. This is an additional armor patent titled Ballistic Strike Plate and Assembly. He [John Bourque] and the Company valued the patent at $1,185,000.